Search Within

Aseem Anand

Formats
  1. Meeting Abstract (42)
  2. Journal Article (19)
Groups
  1. Department of Medicine (52)
  2. Genitourinary Oncology Service (52)
  3. Solid Tumor Oncology Division (52)
  4. Epidemiology and Biostatistics (21)
  5. GSK Faculty (21)
  6. Biostatistics Service (20)

More Groups

People
  1. Howard Scher (46)
  2. Martin Fleisher (34)
  3. Daniel Danila (33)
  4. Glenn Heller (19)
  5. Michael Morris (15)
  6. Hans Lilja (10)

More People

Years
  1. 2025 (1)
  2. 2022 (3)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (35)
  2. Clinical Cancer Research (3)
  3. Journal of Nuclear Medicine (3)
  4. Clinical Chemistry (2)
  5. European Urology (2)
  6. Journal of Molecular Diagnostics (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (35)
  2. Elsevier Science, Inc. (6)
  3. American Association for Cancer Research (5)
  4. Society of Nuclear Medicine (3)
  5. Springer (3)
  6. American Association for Clinical Chemistry (2)

More Publishers

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: A phase 1-2 study
    Journal Article

    Scher, H. I.; Anand, A.; Rathkopf, D.; Shelkey, J.; Morris, M. J.; Danila, D. C.; Larson, S.; Humm, J.; Fleisher, M.; Sawyers, C. L.; more...
    Lancet (2010)

    Fulltext@MSK | Save
  • Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease
    Journal Article

    Donovan, M. J.; Osman, I.; Khan, F. M.; Vengrenyuk, Y.; Capodieci, P.; Koscuiszka, M.; Anand, A.; Cordon-Cardo, C.; Costa, J.; Scher, H. I.
    BJU International (2010)

    Fulltext@MSK | Save
  • Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Scher, H. I.; Beer, T. M.; Higano, C. S.; Taplin, M.; Efstathiou, E.; Anand, A.; Hung, D.; Hirmand, M.; Fleisher, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) in patients with metastatic castration-resistant prostate cancer (CRPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Fleisher, M.; Danila, D. C.; Leversha, M.; Rathkopf, D.; Slovin, S.; Anand, A.; Koscuiszka, M.; Haqq, C.; Scher, H. I.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
    Journal Article

    Leversha, M. A.; Han, J.; Asgari, Z.; Danila, D. C.; Lin, O.; Gonzalez-Espinoza, R.; Anand, A.; Lilja, H.; Heller, G.; Fleisher, M.; more...
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: Concordance with CellSearch assay and association with bone metastases and with survival
    Journal Article

    Helo, P.; Cronin, A. M.; Danila, D. C.; Wenske, S.; Gonzalez-Espinoza, R.; Anand, A.; Koscuiszka, M.; Väänänen, R. M.; Pettersson, K.; Chun, F. K. H.; more...
    Clinical Chemistry (2009)

    Fulltext@MSK | Save
  • Abiraterone acetate and prednisone in patients (Pts) with progressive metastatic castration resistant prostate cancer (CRPC) after failure of docetaxel-based chemotherapy
    Meeting Abstract

    Danila, D. C.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Schwartz, L. H.; Farmer, K.; Anand, A.; Haqq, C.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Analytical validation of the GeXP analyzer and identification of a gene signature biontarker for distinguishing cancer and non-cancer cell types
    Meeting Abstract

    Rai, A. J.; Anand, A.; Fleisher, M.
    Clinical Chemistry (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save